Status:
RECRUITING
Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19
Lead Sponsor:
POCHIWU
Conditions:
PASC Post Acute Sequelae of COVID 19
Eligibility:
All Genders
20-100 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). St...
Eligibility Criteria
Inclusion
- PASC
- above 20 y/o
Exclusion
- Those who cannot cooperate
- Severe schizophrenia
Key Trial Info
Start Date :
December 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 7 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06879925
Start Date
December 2 2024
End Date
April 7 2025
Last Update
March 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Renhe nursing home
New Taipei City, Taiwan
2
Fuxi nursing home
Taipei, Taiwan